PharmaEngine, Inc.
4162
Rank in Stocks
#16024
PharmaEngine, Inc. is a biopharmaceutical firm specializing in the creation and... PharmaEngine, Inc. is a biopharmaceutical firm specializing in the creation and advancement of oncology therapeutics, primarily targeting markets in Taiwan and Europe. Its leading drug candidate is ONIVYDE, an innovative liposomal formulation of irinotecan. This topoisomerase 1 inhibitor is designed to treat metastatic pancreatic cancer. The company's pipeline also includes PEP06, currently in Phase I clinical trials for various cancers, and PEP07. PEP07, a Chk1 inhibitor in preclinical development, is being investigated for its ability to induce DNA damage and programmed cell death (apoptosis), leading to "replication catastrophe" in cancer cells. Established in 2002, PharmaEngine, Inc. maintains its corporate headquarters in Taipei, Taiwan.
Share Price
$1.61
Last synced: 2026-11-10
Market Cap
$231.70M
Change (1 day)
1.34%
Change (1 year)
-27.03%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade PharmaEngine, Inc. (4162)
Category
Healthcare
Dividend history for PharmaEngine, Inc. (4162)
PharmaEngine, Inc. (stock symbol: 4162) made a total of 12 dividend payments.
The sum of all dividends (adjusted for stock splits) is : $0.78
Dividend yield (TTM) : 3.44%
The sum of all dividends (adjusted for stock splits) is : $0.78
Dividend yield (TTM) : 3.44%
Dividend payments for PharmaEngine, Inc. (4162) from 2015 to 2026
Annual dividend payments
| Year | Dividend (stock split adjusted) | Change |
|---|---|---|
| 2026 (TTM) | $0.0617 | -69.17% |
| 2025 | $0.2 | 333.20% |
| 2024 | $0.0462 | -26.32% |
| 2023 | $0.0628 | -30.28% |
| 2022 | $0.09 | -1.81% |
| 2021 | $0.0917 | 437.39% |
| 2020 | $0.0171 | -46.41% |
| 2019 | $0.0318 | -51.16% |
| 2018 | $0.0652 | 18.29% |
| 2017 | $0.0551 | 53.16% |
| 2016 | $0.036 | 60.40% |
| 2015 | $0.0224 | 0.00% |
List of all dividend payments
| Year | Dividend | Change |
|---|---|---|
| 2026 (TTM) | $0.0617 | -69.17% |
| 2025 | $0.2 | 333.20% |
| 2024 | $0.0462 | -26.32% |
| 2023 | $0.0628 | -30.28% |
| 2022 | $0.09 | -1.81% |
| 2021 | $0.0917 | 437.39% |
| 2020 | $0.0171 | -46.41% |
| 2019 | $0.0318 | -51.16% |
| 2018 | $0.0652 | 18.29% |
| 2017 | $0.0551 | 6.54% |
| 2016 | $0.0517 | 60.40% |
| 2015 | $0.0322 | 0.00% |
Dividend payments for similar companies or competitors
| Company | Number of dividend payments | Country |
|---|---|---|
| 0.00% |
US
|
|
| 0.00% |
US
|
|
| 67.00% |
AU
|
|
| 30.00% |
BE
|
|
| 0.00% |
NL
|
Questions about PharmaEngine, Inc.'s dividend per share
What is PharmaEngine, Inc.'s dividend per share?
PharmaEngine, Inc.'s dividend per share over the last twelve months is $0.06, as of Aug 2026.
What was PharmaEngine, Inc.'s dividend per share in 2025?
In 2025, PharmaEngine, Inc.'s dividend per share was $0.20, 333.20% more than in 2024 ($0.05).
How has PharmaEngine, Inc.'s dividend per share changed since 2020?
From 2020 to 2025, PharmaEngine, Inc.'s dividend per share went from $0.02 to $0.20, an average growth of 63.66% a year.